MARKSANS PHARMA
Back to Income Statement
|
MARKSANS PHARMA Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹2,177 Cr | ₹1,852 Cr | ₹1,491 Cr | ₹1,376 Cr | ₹1,134 Cr |
What is the latest Revenue of MARKSANS PHARMA ?
Year | Revenue |
---|---|
Mar2024 | ₹2,177 Cr |
Mar2023 | ₹1,852 Cr |
Mar2022 | ₹1,491 Cr |
Mar2021 | ₹1,376 Cr |
Mar2020 | ₹1,134 Cr |
How is Revenue of MARKSANS PHARMA Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹2,177 Cr | 17.56 | |
Mar2023 | ₹1,852 Cr | 24.23 | |
Mar2022 | ₹1,491 Cr | 8.33 | |
Mar2021 | ₹1,376 Cr | 21.33 | |
Mar2020 | ₹1,134 Cr | - |
Compare Revenue of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹12,118.6 Cr | 14.1% | 4.9% | 75.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹415,697.0 Cr | 0.6% | -2.1% | 16.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,449.0 Cr | 4.3% | 6.5% | 63.9% | Stock Analytics | |
CIPLA | ₹117,778.0 Cr | 3.6% | 0.2% | 2.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,871.0 Cr | 3% | -8.4% | 0% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,046.2 Cr | 3.2% | -1% | 27.4% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | 14.1% |
4.9% |
75.8% |
SENSEX | 0.2% |
-0.1% |
7.2% |
You may also like the below Video Courses